EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Novel quinoline derivatives with broad‐spectrum antiprotozoal activities

Carla B Hartman, Phelelisiwe S Dube, Lesetja J Legoabe, Natascha Van Pelt, An Matheeussen, Guy Caljon, Richard M Beteck

Archiv der Pharmazie · 2024

DOI: 10.1002/ardp.202300319 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archiv der Pharmazie, 2024. Verfasst von Carla B Hartman und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa. Hauptthemen laut MEDLINE: Quinolines, Leishmania infantum, Antiprotozoal Agents, Trypanosoma cruzi. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: South African Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Several quinoline derivatives incorporating arylnitro and aminochalcone moieties were synthesized and evaluated in vitro against a broad panel of trypanosomatid protozoan parasites responsible for sleeping sickness ( Trypanosoma brucei rhodesiense ), nagana ( Trypanosoma brucei brucei ), Chagas disease ( Trypanosoma cruzi ), and leishmaniasis ( Leishmania infantum ). Several of the compounds demonstrated significant antiprotozoal activity. Specifically, compounds 2c , 2d , and 4i displayed submicromolar activity against T. b. rhodesiense with half‐maximal effective concentration (EC 50 ) values of 0.68, 0.8, and 0.19 µM, respectively, and with a high selectivity relative to human lung fibroblasts and mouse primary macrophages (∼100‐fold). Compounds 2d and 4i also showed considerable activity against T. b. brucei with EC 50 values of 1.4 and 0.4 µM, respectively.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

QuinolinesLeishmania infantumAntiprotozoal AgentsTrypanosoma cruziParasitic Sensitivity TestsTrypanosoma brucei rhodesienseAnimalsMiceHumansStructure-Activity RelationshipMolecular StructureTrypanosoma brucei bruceiDose-Response Relationship, DrugMacrophagesFibroblasts

Stichwörter der Autor:innen

anti‐infectivesarylnitrochalconesprotozoalquinoline

Substanzen

QuinolinesAntiprotozoal Agents

Autor:innen und Institutionen

  • Centre of Excellence for Pharmaceutical Sciences, North-West University, Potchefstroom, South Africa.
  • Laboratory of Microbiology, Parasitology and Hygiene, Infla-Med Centre of Excellence, University of Antwerp, Antwerp, Belgium.

Förderung

  • South African Medical Research Council

Zitieren

APA

Hartman, C. B., Dube, P. S., Legoabe, L. J., Van Pelt, N., Matheeussen, A., Caljon, G., & Beteck, R. M. (2024). Novel quinoline derivatives with broad‐spectrum antiprotozoal activities. Archiv der Pharmazie. https://doi.org/10.1002/ardp.202300319

Vancouver

Hartman CB, Dube PS, Legoabe LJ, Van Pelt N, Matheeussen A, Caljon G, et al. Novel quinoline derivatives with broad‐spectrum antiprotozoal activities. Archiv der Pharmazie. 2024. doi:10.1002/ardp.202300319

BibTeX
@article{Hartman2024,
  author = {Hartman, Carla B and Dube, Phelelisiwe S and Legoabe, Lesetja J and Van Pelt, Natascha and Matheeussen, An and Caljon, Guy and Beteck, Richard M},
  title = {Novel quinoline derivatives with broad‐spectrum antiprotozoal activities},
  journal = {Archiv der Pharmazie},
  year = {2024},
  doi = {10.1002/ardp.202300319}
}
Kostenlos starten →